SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-16-000056
Filing Date
2016-05-04
Accepted
2016-05-04 16:10:04
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 467464
2 exhibit10-1.htm EX-10.1 169131
3 exhibit10-2.htm EX-10.2 31536
4 exhibit10-3.htm EX-10.3 149484
5 CEO CERTIFICATION exhibit31-1.htm EX-31.1 10886
6 CFO CERTIFICATION exhibit31-2.htm EX-31.2 10888
7 PEO CERTIFICATION exhibit32-1.htm EX-32.1 2905
8 PFO CERTIFICATION exhibit32-2.htm EX-32.2 2817
  Complete submission text file 0001125345-16-000056.txt   3441713

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mgnx-20160331.xml EX-101.INS 519974
10 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20160331.xsd EX-101.SCH 31182
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgnx-20160331_cal.xml EX-101.CAL 38662
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgnx-20160331_def.xml EX-101.DEF 135386
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20160331_lab.xml EX-101.LAB 466462
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20160331_pre.xml EX-101.PRE 250093
Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9640 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 161619383
SIC: 2834 Pharmaceutical Preparations